Brand | Abnova |
Product type | Primary antibodies |
Reactivity | Bovine,Chicken,Clawed frog,Dog,Frog,Human,Mouse,Primates,Rat,Zebra fish |
Host species | Rabbit |
Applications | WB-Ti |
Brand: | Abnova |
Reference: | PAB9690 |
Product name: | EphrinB (phospho Y298) polyclonal antibody |
Product description: | Rabbit polyclonal antibody raised against synthetic phosphopeptide of EphrinB. |
Immunogen: | Synthetic phosphopeptide corresponding to residues surrounding Y298 of Xenopus EphrinB. |
Protein accession: | P28693 |
Form: | Liquid |
Recommend dilutions: | Western Blot (1:1000) The optimal working dilution should be determined by the end user. |
Storage buffer: | In 10 mM HEPES, 150 mM NaCl, pH 7.5 (50% glycerol, 10% BSA) |
Storage instruction: | Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
Quality control testing: | Antibody Reactive Against Synthetic Peptide. |
Product type: | Primary antibodies |
Host species: | Rabbit |
Antigen species / target species: | Frog |
Reactivity: | Bovine,Chicken,Clawed frog,Dog,Frog,Human,Mouse,Primates,Rat,Zebra fish |
Application image: | ![]() |
Application image note: | Western blot of rat testis lysate showing specific immunolabeling of the ~46k EphrinB phosphorylated at Tyr298 (Control, lane 1). The phosphospecificity of this labeling is shown in the second lane (lambda-phosphatase: lambda-Ptase, lane 2). The blot is identical to the control except that it was incubated in lambda-Ptase (1200 units for 30 min) before being exposed to the EphrinB (phospho Y298) polyclonal antibody (Cat # PAB9690). The immunolabeling of the EphrinB band is completely eliminated by treatment with lambda-Ptase. |
Applications: | WB-Ti |
Shipping condition: | Dry Ice |
Publications: | Neuronal, glial, and epithelial localization of gamma-aminobutyric acid transporter 2, a high-affinity gamma-aminobutyric acid plasma membrane transporter, in the cerebral cortex and neighboring structures.Conti F, Zuccarello LV, Barbaresi P, Minelli A, Brecha NC, Melone M. J Comp Neurol. 1999 Jul 5;409(3):482-94. |